Neogen

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety and Animal Safety. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Neogen reports robust Q2 earnings, targets $1B revenue by 2025

Neogen's Q2 2023 earnings call highlighted impressive revenue growth, improved margins, and strategic focus on integration and customer service.
While facing challenges related to increased debt levels and operational complexities, Neogen aims for ambitious revenue and EBITDA targets by 2025.
The company's performance underscores its potential for continued success in the Food Safety and Animal Safety segments through organic growth and financial discipline.

Neogen reports robust Q3 earnings, focuses on data analytics growth

Neogen's Q3 performance reflects strong revenue growth and strategic focus on data analytics for food security. While challenges exist in certain business segments, the company remains optimistic about long-term opportunities and integration synergies.

Neogen reports stellar Q4 results, eyes growth through integration

Neogen's Q4 2023 earnings call highlighted robust financial performance, successful integration of acquired divisions, and strategic outlook for fiscal '24. The company's focus on growth, innovation, and market expansion positions it well for continued success in the food safety and animal health sectors.

Neogen reports robust Q1 earnings, eyes growth amid regional challenges

Neogen's Q1 2024 showed strong revenue growth but faced challenges in core revenue.
The company highlighted progress in key segments like Food Safety and genomics.
Efficiency issues from ERP implementation impacted revenue timing.
Management remains optimistic about the full-year outlook despite regional challenges.

Neogen reports flat Q2 revenues, focuses on integration and market challenges

Neogen's Q2 performance was mixed, with strengths in certain segments and challenges in others. The company remains optimistic about its long-term prospects despite market headwinds.

Neogen reports improved margins in Q3 despite integration challenges

Neogen's Q3 2024 performance showed improvements in gross margin and EBITDA, but challenges with shipping inefficiencies and integration impacted revenue growth. The company is focused on resolving operational inefficiencies and regaining lost customers to achieve long-term growth goals.

Neogen reports Q4 revenue growth but faces EBITDA margin decline

Neogen's Q4 showed mixed performance with revenue growth but declining EBITDA margins.
The company faces challenges in the soft food safety end market and supply constraints.
However, Neogen is focusing on innovation and underpenetrated markets for future growth.

Neogen reports Q1 revenue decline, focuses on food safety growth

Neogen's Q1 performance showed mixed results with revenue decline and EBITDA pressure.
The company's strengths lie in its strategic positioning in food safety and customer-focused approach.
Challenges persist in certain segments, requiring operational adjustments for sustained growth.
Identified opportunities in geographic expansion and strategic investments can drive future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Neogen Corp. engages in the provision of development, manufacture, and marketing of food and animal safety products. It operates through the Food Safety and Animal Safety segments. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

NEOGEN (NEOG) aims to better serve the biomedical research community with a comprehensive and affordable solution for the genetic background testing of their mouse models via the partnership.

NEOGEN (NEOG), Transnetyx Partner to Advance Mouse Genotyping

LINCOLN, Neb., Oct. 28, 2020 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) today announced the launch of Igenity® Feeder, a DNA tool designed to assist cattle producers in the stocker and backgrounder phase to rank and manage feeder cattle according to their genetic potential for...

Neogen launches Igenity® Feeder, a new commercial DNA sorting tool

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock?

Neogen (NEOG) Down 5.8% Since Last Earnings Report: Can It Rebound?

Clorox

Cantel Medical

Ecolab

Kimberly-Clark

Sonoma Pharmaceuticals

The Covid-19 pandemic has given a significant boost to many industries such as manufacturers of gloves, masks, sanitizers, PPE (personal protective equipment), health insurance providers, and many more related areas.

These Surface Disinfectant Stocks Have Strong Upside Potential

LANSING, Mich., Oct. 15, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched a new food extraction method that expands the capabilities of select Reveal® 3-D food allergen tests to include the direct testing of food products. Neogen's new Reveal 3-D...

Neogen launches Reveal® 3-D food extraction buffer

Neogen (NEOG) possesses solid growth attributes, which could help it handily outperform the market.

Is Neogen (NEOG) a Solid Growth Stock? 3 Reasons to Think " Yes "

Simpson Manufacturing

NEW YORK, Oct. 1, 2020 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 7: S&P MidCap 400 constituent Pool Corp. (NASD:POOL) will replace E*TRADE...

Pool Set to Join S&P 500; Neogen & Simpson Manufacturing to Join S&P MidCap 400; Others to Join S&P SmallCap 600

AmerisourceBergen

Chemed

Novo Nordisk

ResMed

As the world grapples with an unprecedented coronavirus pandemic, five health care stocks that have outperformed the Standard & Poor's 500 Index by at least 5% in the year to date are AmerisourceBergen Corp. (NYSE:ABC), Chemed Corp. (NYSE:CHE), Neogen Corp. (NASDAQ:NEOG), Novo Nordisk A/S (NYSE:NVO) and ResMed Inc. (NYSE:RMD) according to the All-in-One Screener, a Premium feature of GuruFocus.

5 Health Care Stocks Outperforming the S&P 500

NEOGEN's (NEOG) segmental revenues improve for the fiscal first quarter on strong sales of cleaners, disinfectants and sanitizers.

NEOGEN (NEOG) Q1 Earnings and Revenues Surpass Estimates

Neogen Corporation (NEOG) CEO John Adent on Q1 2021 Results - Earnings Call Transcript

Neogen (NEOG) delivered earnings and revenue surprises of 11.11% and 5.07%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?

Neogen (NEOG) Surpasses Q1 Earnings and Revenue Estimates

LANSING, Mich., Sept. 16, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched an improved test that rapidly detects gluten in food products, raw ingredients, and environmental samples.

Neogen launches improved test for gluten

Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Neogen (NEOG) Q1 Earnings Expected to Decline

LANSING, Mich., Sept. 3, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has entered into a sponsorship agreement with the National FFA that will support the agricultural organization and help fight the spread of COVID-19.

Neogen, FFA partner to support organization, fight COVID-19

NEOGEN (NEOG) completes organic certified water treatment program with the latest certification.

OMRI Clears NEOGEN's AquaPrime Peraside 15 as USDA Compliant

Why Is Neogen (NEOG) Up 0.7% Since Last Earnings Report?

NEOGEN's (NEOG) BioSentry 904 Disinfectant approved by the EPA for use against the COVID-19-causing SARS-CoV-2 virus.

EPA Validates NEOGEN's Disinfectant for Use Against COVID-19

LEXINGTON, Ky., Aug. 13, 2020 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today that its BioSentry® 904 Disinfectant has been proven effective by the U.S.

Neogen's BioSentry® 904 Disinfectant proven effective against SARS-CoV-2, the virus that causes COVID-19

LANSING, Mich., Aug. 3, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has completed the previously announced acquisition of the U.S.

Neogen completes acquisition of U.S. rights and related assets of Elanco's StandGuard® insecticide

Neogen's (NEOG) Animal Safety revenues improve in the fourth quarter on strong sales of cleaners, disinfectants and sanitizers.

Neogen (NEOG) Q4 Earnings Beat Estimates, Margins Expand

Neogen Corporation (NEOG) CEO John Adent on Q4 2020 Results - Earnings Call Transcript

Neogen (NEOG) delivered earnings and revenue surprises of 3.33% and -1.69%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?

Neogen (NEOG) Q4 Earnings Top Estimates

LANSING, Mich., July 21, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that revenues for the fourth quarter of its 2020 fiscal year, which ended May 31, were $109,074,000, compared to $109,762,000 the prior year quarter.

Neogen reports fiscal 2020 results

LANSING, Mich., July 16, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that, in line with yesterday's Federal Trade Commission (FTC) press release, it plans to acquire the U.S.

Neogen plans to acquire U.S. rights and related assets to Elanco's StandGuard® insecticide

LANSING, Mich., July 15, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched an advanced test system that automatically detects microorganisms in a fraction of the time of traditional testing methods. Neogen's new Soleris® Next Generation (NG) can...

News for Neogen Stock (NEOG)